Form 4: STERIS plc Executive Acquires Shares and Stock Options
SEC Form 4
Karen L. Burton, VP & CAO of STERIS plc, reports acquisition of shares and stock options.
Summary
- On June 4, 2024, Karen L. Burton, VP & CAO of STERIS plc, acquired 918 ordinary shares at $0 price.
- Following the transaction, Burton directly owns 4,388 ordinary shares, including 2,416 restricted shares that vest over time.
- Burton also acquired an employee stock option for 3,144 ordinary shares at an exercise price of $251.34, exercisable in installments starting June 4, 2025, and expiring on June 4, 2034.
- Following the transaction, Burton directly owns 3,144 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of shares and options suggests confidence, but it's not overwhelmingly positive.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of restricted shares and exercisability of stock options suggest a long-term incentive structure for the executive.
Industry Context
Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders. This filing reflects standard compensation practices.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted shares, are common across the medical device and healthcare industries.
- Companies like Medtronic, Johnson & Johnson, and Danaher also utilize similar equity-based compensation to incentivize their executives.
- The vesting schedules and exercise prices are generally aligned with industry benchmarks for long-term performance incentives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.
- Employees may view the stock option grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of transaction: Acquisition of ordinary shares and employee stock options. |
| 06/04/2025 | First vesting date for a portion of the restricted ordinary shares. |
| 06/04/2025 | First date that a portion of the employee stock options become exercisable. |
| 06/04/2034 | Expiration date of the employee stock options. |
| 06/06/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.